Skip to main content

Together we are beating cancer

Donate now

Cancer News

Amal Iman

Amal is a graduate at Cancer Research UK. She has worked in a range of teams including Cancer Intelligence, Health Community Engagement and Science Policy. She now works in the Digital News team.
Showing 5 out of 17 results
A man and woman sat in the park on a sunny day. The photograph shows them from behind, as they look out on a lake.

The way people dress when they’re in the sun could be influencing where they get melanoma – the most serious form of skin cancer. The way people dress when they’re in the sun could be influencing where they get melanoma – the most serious form of skin cancer.

by Amal Iman, Tim Gunn | News | 26 May 2025

26 May 2025

The 50-layer pink dress made from clothes donated to the TK Maxx Give Up Clothes for Good campaign showcases a tight bodice and a flowing train.

We're celebrating the £50m raised by TK Maxx with a 50-layer dress modelled by Naomie Harris - and we're highlighting how their support has helped fund research into children's and young people's cancers. We're celebrating the £50m raised by TK Maxx with a 50-layer dress modelled by Naomie Harris - and we're highlighting how their support has helped fund research into children's and young people's cancers.

by Amal Iman | News | 21 May 2025

21 May 2025

A breast cancer cell seen through an electron microscope.

Our Partner trial has found a new treatment combination for women with inherited breast cancers, with all 39 patients who received it surviving the critical three years after surgery Our Partner trial has found a new treatment combination for women with inherited breast cancers, with all 39 patients who received it surviving the critical three years after surgery

by Amal Iman, Tim Gunn | News | 13 May 2025

13 May 2025

A microscope image showing purple cancer cells against a black background.

PRRDetect, developed by scientists at the University of Cambridge, picks out cancers that are vulnerable to immunotherapy by scanning for mutation patterns. PRRDetect, developed by scientists at the University of Cambridge, picks out cancers that are vulnerable to immunotherapy by scanning for mutation patterns.

by Amal Iman, Tim Gunn | News | 10 April 2025

10 April 2025